CompletedNot Applicable

Fever After Misoprostol Administration for the Treatment of Primary Postpartum Hemorrhage

Ecuador50 participantsStarted 2010-02

Plain-language summary

This study will evaluate side effects after sublingual misoprostol (600 mcg) as a first-line treatment for primary postpartum hemorrhage (PPH) due to suspected uterine atony.

Who can participate

Age range14 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Able and willing to give informed consent * Vaginal delivery * Postpartum hemorrhage due to suspected uterine atony * Oxytocin given during 3rd stage of labor Exclusion Criteria: * Known allergy to prostaglandins or misoprostol * Underwent cesarean section * Postpartum hemorrhage NOT due to suspected uterine atony * Oxytocin NOT given during 3rd stage of labor * Severe ill health * Unable to give informed consent

What they're measuring

Rate of fever above 40.0 degrees centigrade

Timeframe: Body temperature measured at 60 minutes and 90 minutes post-treatment with misoprostol for PPH

Trial details

NCT IDNCT01080846

SponsorGynuity Health Projects

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-08

View on ClinicalTrials.gov More Postpartum Hemorrhage trials